Article
Matrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first-line, platinum-based chemotherapy.
Cancer - 15 Jul 2012
Zhao Xueying, Wang Xun, Wu Wenting, Gao Zhiqiang, Wu Junjie, Garfield David H, Wang Haijian, Wang Jiucun, Qian Ji, Li Huan, Jin Li, Li Qiang, Han Baohui, Lu Daru, Bai Chunxue
Abstract excerpt
BACKGROUND: Matrix metalloproteinase-2 (MMP-2) is well known for its critical role in cell survival and cancer development. It also plays an important role in hematopoietic recovery after chemotherapy-induced myelosuppression. In this study, the authors investigated the association of MMP-2 polym...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
